Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2021-03-23 Capital/Financing Update
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the acquisition of convertible bonds before maturity by the company GtreeBNT. It details the specific bond series, acquisition amount, date, and reason. This type of corporate action regarding debt instruments and capital structure changes falls under the 'Capital/Financing Update' category.
2021-03-23 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously submitted 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). The document contains detailed corporate information, including board changes, shareholder meeting results, and capital structure updates, which are characteristic of an Annual Report filing. Although it is a correction, it functions as the official annual disclosure document. FY 2020
2021-03-22 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director. This falls under the category of board or management changes, which is classified as MANG.
2021-03-22 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company 'HLB Therapeutics' (formerly GtreeBNT). It lists specific agenda items (election of directors and auditors) and the outcome of the votes (approved or rejected). This falls directly under the category of Declaration of Voting Results.
2021-03-19 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the underlying calculation methodology due to a decline in market price. This falls under capital structure changes related to debt-to-equity instruments, which is best classified as a Capital/Financing Update (CAP).
2021-03-19 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (HLB Therapeutics, formerly GtreeBNT) regarding the acquisition of its own convertible bonds before maturity. This type of corporate action, involving the repurchase of debt instruments, falls under capital structure changes and financing updates. Given the specific nature of the transaction (early redemption of convertible bonds), it is best classified as a Capital/Financing Update.
2021-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.